Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-29T10:40:08.623Z Has data issue: false hasContentIssue false

Drug Treatment of Panic Disorder

Further Comment

Published online by Cambridge University Press:  02 January 2018

Isaac M. Marks*
Affiliation:
Institute of Psychiatry, London SE5 8AF
Metin Başoǧlu
Affiliation:
Institute of Psychiatry
Homa Noshirvani
Affiliation:
Dean Foundation, Madison, USA
John Greist
Affiliation:
Institute of Psychiatry
Richard P. Swinson
Affiliation:
Clarke Institute, Toronto, Canada
Geraldine O'Sullivan
Affiliation:
Institute of Psychiatry
*
Correspondence

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cross-National Collaborative Panic Study, Second Phase Investigators (1992) Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. British Journal of Psychiatry, 160, 191202.Google Scholar
Klerman, G. L. (1992) Drug treatment of panic disorders. Reply to comment by Marks and associates. British Journal of Psychiatry, 161, 465471.Google Scholar
Margraf, J., Ehlers, A., Roth, W. T., et al (1991) How ‘blind’ are double-blind studies? Journal of Consulting and Clinical Psychology, 59, 184187.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.